187 related articles for article (PubMed ID: 11056767)
1. Orlistat (Xenical) in the management of obesity.
Cheah JS
Ann Acad Med Singap; 2000 Jul; 29(4):419-20. PubMed ID: 11056767
[No Abstract] [Full Text] [Related]
2. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial.
Chanoine JP; Hampl S; Jensen C; Boldrin M; Hauptman J
JAMA; 2005 Jun; 293(23):2873-83. PubMed ID: 15956632
[TBL] [Abstract][Full Text] [Related]
3. Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction programme in obese Finns.
Karhunen L; Franssila-Kallunki A; Rissanen P; Valve R; Kolehmainen M; Rissanen A; Uusitupa M
Int J Obes Relat Metab Disord; 2000 Dec; 24(12):1567-72. PubMed ID: 11126207
[TBL] [Abstract][Full Text] [Related]
4. [Orlistat (Xenical)].
Crenier L; Sternon J
Rev Med Brux; 1999 Jun; 20(3):159-63. PubMed ID: 10429540
[TBL] [Abstract][Full Text] [Related]
5. [Use of orlistat (xenical) in the treatment of women with obesity and disorders of menstrual cycle].
Totoian ES; Frolova NG; Manasian AS; Akopian MA; Magevosian AA; Arutiunian ZhS
Georgian Med News; 2006 Oct; (139):20-2. PubMed ID: 17077458
[TBL] [Abstract][Full Text] [Related]
6. One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor.
Finer N; James WP; Kopelman PG; Lean ME; Williams G
Int J Obes Relat Metab Disord; 2000 Mar; 24(3):306-13. PubMed ID: 10757623
[TBL] [Abstract][Full Text] [Related]
7. Medical management of obesity.
Berke EM; Morden NE
Am Fam Physician; 2000 Jul; 62(2):419-26. PubMed ID: 10929704
[TBL] [Abstract][Full Text] [Related]
8. Orlistat. No hurry...
Can Fam Physician; 1999 Oct; 45():2331-3, 2336-8, 2343-5 passim. PubMed ID: 10540693
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacological sheet. Orlistat, oral administration (Xenical, Alli). ].
J Pharm Belg; 2009 Jun; (2):67-8. PubMed ID: 19739531
[No Abstract] [Full Text] [Related]
10. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.
Sjöström L; Rissanen A; Andersen T; Boldrin M; Golay A; Koppeschaar HP; Krempf M
Lancet; 1998 Jul; 352(9123):167-72. PubMed ID: 9683204
[TBL] [Abstract][Full Text] [Related]
11. The use of orlistat in the treatment of obesity, dyslipidaemia and Type 2 diabetes.
Nelson RH; Miles JM
Expert Opin Pharmacother; 2005 Nov; 6(14):2483-91. PubMed ID: 16259579
[TBL] [Abstract][Full Text] [Related]
12. More about orlistat.
Lucas KH; Kaplan-Machlis B
Pharmacotherapy; 2000 Jul; 20(7):872-3. PubMed ID: 10907983
[No Abstract] [Full Text] [Related]
13. Orlistat, a new lipase inhibitor for the management of obesity.
Heck AM; Yanovski JA; Calis KA
Pharmacotherapy; 2000 Mar; 20(3):270-9. PubMed ID: 10730683
[TBL] [Abstract][Full Text] [Related]
14. The long-term influence of orlistat on dietary intake in obese subjects with components of metabolic syndrome.
Svendsen M; Helgeland M; Tonstad S
J Hum Nutr Diet; 2009 Feb; 22(1):55-63. PubMed ID: 19192027
[TBL] [Abstract][Full Text] [Related]
15. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
[TBL] [Abstract][Full Text] [Related]
16. Orlistat (Xenical).
MacConnachie AM
Intensive Crit Care Nurs; 1999 Oct; 15(5):298-9. PubMed ID: 10808826
[TBL] [Abstract][Full Text] [Related]
17. [Xenical--a modern perspective drug for the treatment of obesity (review)].
Mkrtumian AM; Biriukova EV
Ter Arkh; 2007; 79(10):35-9. PubMed ID: 18154143
[No Abstract] [Full Text] [Related]
18. Effect of orlistat on blood cyclosporin concentration in an obese heart transplant patient.
Nägele H; Petersen B; Bonacker U; Rödiger W
Eur J Clin Pharmacol; 1999 Nov; 55(9):667-9. PubMed ID: 10638396
[TBL] [Abstract][Full Text] [Related]
19. Orlistat, a gastrointestinal lipase inhibitor, in therapy of obesity with concomitant hyperlipidemia.
Micić D; Ivković-Lazar T; Dragojević R; Jorga J; Stokić E; Hajduković Z
Med Pregl; 1999; 52(9-10):323-33. PubMed ID: 10624380
[TBL] [Abstract][Full Text] [Related]
20. Effect of weight loss with or without orlistat treatment on adipocytokines, inflammation, and oxidative markers in obese women.
Bougoulia M; Triantos A; Koliakos G
Hormones (Athens); 2006; 5(4):259-69. PubMed ID: 17178701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
